Newcastle-based biotech InvenireX has secured £2 million in Seed funding to accelerate commercialisation of its DNA nanotechnology platform that can detect disease at the earliest biological stages.
The round is led by…
The UK’s next big biotech? InvenireX secures £2M to commercialise its disease detection platform
